Abstract
Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
Y Inada, T Wada, Y Shibouta, M Ojima, T Sanada, K Ohtsuki, K Itoh, K Kubo, Y Kohara and T Naka
Journal of Pharmacology and Experimental Therapeutics March 1994, 268 (3) 1540-1547;
Y Inada
T Wada
Y Shibouta
M Ojima
T Sanada
K Ohtsuki
K Itoh
K Kubo
Y Kohara
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Abstract
Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
Y Inada, T Wada, Y Shibouta, M Ojima, T Sanada, K Ohtsuki, K Itoh, K Kubo, Y Kohara and T Naka
Journal of Pharmacology and Experimental Therapeutics March 1, 1994, 268 (3) 1540-1547;
Abstract
Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats.
Y Inada, T Wada, Y Shibouta, M Ojima, T Sanada, K Ohtsuki, K Itoh, K Kubo, Y Kohara and T Naka
Journal of Pharmacology and Experimental Therapeutics March 1, 1994, 268 (3) 1540-1547;
Jump to section
Related Articles
Cited By...
Similar Articles
Advertisement